This trial is active, not recruiting.

Condition anemia
Sponsor OrSense, Ltd.
Start date November 2011
End date October 2013
Trial size 150 participants
Trial identifier NCT01917487, QD04.5.1-25


The purpose of the study is to define the precision, accuracy and variability of the NBM-200 system in non invasive blood Hemoglobin (Hb) measurements relative to the laboratory blood analyzer by comparing two consecutive Hb values obtained by the NBM system to venous values.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Time perspective prospective

Primary Outcomes

Compare the Hb values from the Noninvasive Blood Monitor(NBM200) series against the Hb from the lab blood analyser on healthy volunteers and oncology patients
time frame: 1 day

Eligibility Criteria

Male or female participants from 18 years up to 95 years old.

Inclusion Criteria: - Aged 18 years and over - Healthy volunteers - Anemia patients Exclusion Criteria: - Participants under the age of 18 years - Patients with significant deformity, degenerative changes or oedema of the thumb or index fingers - Patients with localized infection, ulceration or skin breaks involving the fingers - Patients with vascular disease or Raynaud's phenomenon affecting the fingers - Participants who are unable to give informed written consent - Pregnancy

Additional Information

Official title A Trial to Evaluate the Precision and Accuracy of the NBM-200 Series When Used in a Continuous Prospective Mode
Principal investigator Ohad Cohen, Prof.
Description Each subject will be placed in a comfortable position in a temperature regulated room. Participants will have two consecutive non invasive (NBM) measurements taken which involves inserting the thumb into a ring shaped sensor. After each non invasive measurement the sensor will be removed. Each measurement takes approximately 85 seconds and involves the finger cuff inflating (to over systolic pressure) and deflating several times in quick successions in order to measure and calculate the Hb values. The two non invasive measurements will be performed using the same finger. After the NBM system testing is complete and recorded, the subject will have a venous (venipuncture) blood sample collected in order to provide two blood tests performed on two different models of routine automated complete blood count or Hb blood analyzers. Addendum: Reproducibility Procedure (optional) Each subject will be measured by each one of the three operators, three NBM system units, 3 times consecutively (without removal) on his right thumb and right index finger. The order of each measurement sequence will be randomized (thumb/index). There will be an intermission of 3 to 5 minutes between the 3 measurement sets taken on each participant. In case of a longer intermission, the subject will be measured again and the previous results will be excluded.
Trial information was received from ClinicalTrials.gov and was last updated in September 2013.
Information provided to ClinicalTrials.gov by OrSense, Ltd..